Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.45 EUR | +1.90% |
|
-2.36% | +9.47% |
07-03 | BRITISH AMERICAN TOBACCO : RBC reiterates its Neutral rating | ZD |
07-02 | BRITISH AMERICAN TOBACCO : UBS remains Neutral | ZD |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- One of the major weak points of the company is its financial situation.
- The company's enterprise value to sales, at 3.28 times its current sales, is high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.47% | 69.4B | - | ||
+7.80% | 158B | B- | ||
+14.00% | 22.13B | A- | ||
+33.69% | 6.73B | B- | ||
+107.14% | 2.67B | - | C+ | |
-1.41% | 1.82B | - | ||
-2.84% | 1.73B | - | D+ | |
-29.41% | 1.17B | - | B+ | |
0.00% | 643M | - | - | |
+25.38% | 582M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- BMTA Stock
- Ratings British American Tobacco p.l.c.